BGI Genomics

BGI Genomics offers advanced genomic sequencing and bioinformatics solutions for precision medicine, research, and diagnostics. The company develops diagnostic products, including kits and mass spectrometry platforms, utilizing its genomic data and technological expertise. They combine high-throughput sequencing with sophisticated data interpretation for diverse life science applications and clinical needs.

Established in September 1999 as the Beijing Genomics Institute, BGI was founded by scientists Wang Jian, Yu Jun, Yang Huanming, and Liu Siqi. Their core insight was the transformative power of large-scale genomic sequencing for health and disease, which led to their participation in the Human Genome Project. This early endeavor laid the foundation for their global genomic leadership.

BGI Genomics serves academic, pharmaceutical, healthcare, and agricultural clients, applying its services from scientific discovery to clinical diagnostics. The company's mission is to leverage genomics for humanity's benefit, striving to make advanced genomic technologies accessible and effective for improving global health and fostering innovation.